Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis. | Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis. Yoon T, Ha JW, Pyo JY, Ko E, Ahn SS, Song JJ, Park YB, Lee SW., Free PMC Article | 09/29/2024 |
Sirt7/HIC1 complex participates in hyperglycaemia-mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory. | Sirt7/HIC1 complex participates in hyperglycaemia-mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory. Lu L, Zhu M, Wu Q, Sun Z, Chen X, Miao C., Free PMC Article | 08/1/2024 |
The significance of Syndecan 1, a new marker for endothelial dysfunction, in cases of fetal growth retardation. | The significance of Syndecan 1, a new marker for endothelial dysfunction, in cases of fetal growth retardation. Oğuz Y, Ağaoğlu RT, Ulusoy CO, Kurt D, Özgürlük İ, Soysal Ç, Yılmaz Vural Z, Yakut Yücel K. | 05/28/2024 |
Soluble Endoglin and Syndecan-1 levels predicts the clinical outcome in COVID-19 patients. | Soluble Endoglin and Syndecan-1 levels predicts the clinical outcome in COVID-19 patients. Rajan R, Hanifah M, Mariappan V, Anand M, Balakrishna Pillai A. | 02/24/2024 |
CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway. | CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway. Green LR, Issa R, Albaldi F, Urwin L, Thompson R, Khalid H, Turner CE, Ciani B, Partridge LJ, Monk PN., Free PMC Article | 02/16/2024 |
CLINICAL VALUE OF SYNDECAN-1 LEVELS IN TRAUMA BRAIN INJURY: A META-ANALYSIS. | CLINICAL VALUE OF SYNDECAN-1 LEVELS IN TRAUMA BRAIN INJURY: A META-ANALYSIS. Xie WW, Ding YJ, Bhandari S, Li H, Chen HS, Jin SW, Weng HX, Hao Y. | 02/7/2024 |
Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases. | Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases. Zhang X, Zhao Y, Liu L, He Y. | 01/9/2024 |
Neutrophil Extracellular Traps Are Induced by Coronavirus 2019 Disease-Positive Patient Plasma and Persist Longitudinally: A Possible Link to Endothelial Dysfunction as Measured by Syndecan-1. | Neutrophil Extracellular Traps Are Induced by Coronavirus 2019 Disease-Positive Patient Plasma and Persist Longitudinally: A Possible Link to Endothelial Dysfunction as Measured by Syndecan-1. Kelly EJ, Oliver MA, Carney BC, Kolachana S, Moffatt LT, Shupp JW. | 12/21/2023 |
SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. | SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. Zhang CL, Shen Q, Liu FD, Yang F, Gao MQ, Jiang XC, Li Y, Zhang XY, En GE, Pan X, Pang B., Free PMC Article | 11/3/2023 |
Binding of Trichinella spiralis C-type lectin with syndecan-1 on intestinal epithelial cells mediates larval invasion of intestinal epithelium. | Binding of Trichinella spiralis C-type lectin with syndecan-1 on intestinal epithelial cells mediates larval invasion of intestinal epithelium. Wang Z, Lu QQ, Weng MM, Li YL, Han LL, Song YY, Shi YL, Liu RD, Cui J, Wang ZQ., Free PMC Article | 10/4/2023 |
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis. | Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis. Cerbelli B, Pisano A, Pignataro MG, Pernazza A, Botticelli A, Carosi M, Costarelli L, Allegretti M, d'Amati G, Cordone I., Free PMC Article | 08/30/2023 |
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression. | Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression. Lazniewska J, Li KL, Johnson IRD, Sorvina A, Logan JM, Martini C, Moore C, Ung BS, Karageorgos L, Hickey SM, Prabhakaran S, Heatlie JK, Brooks RD, Huzzell C, Warnock NI, Ward MP, Mohammed B, Tewari P, Martin C, O'Toole S, Edgerton LB, Bates M, Moretti P, Pitson SM, Selemidis S, Butler LM, O'Leary JJ, Brooks DA., Free PMC Article | 08/25/2023 |
The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis. | The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis. Ghondaghsaz E, Khalaji A, Norouzi M, Fraser DD, Alilou S, Behnoush AH., Free PMC Article | 08/9/2023 |
The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. | The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. Hassan N, Bückreiß N, Efing J, Schulz-Fincke M, König P, Greve B, Bendas G, Götte M., Free PMC Article | 04/12/2023 |
Evaluation of Intrafollicular Syndecan 1, Glypican 3, and Spermidine Levels in Women with Diminished Ovarian Reserve. | Evaluation of Intrafollicular Syndecan 1, Glypican 3, and Spermidine Levels in Women with Diminished Ovarian Reserve. Gokce S, Herkiloglu D, Cevik O, Turan V. | 03/15/2023 |
High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer. | High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer. Li Z, He S, Liu J, Zhi X, Yang L, Zhang J, Zhao R, Zhang R, Li L, Wang W., Free PMC Article | 03/14/2023 |
C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis. | C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis. Gui XY, Rabkin SW. | 03/7/2023 |
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer. | Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer. Martini C, Logan JM, Sorvina A, Gordon C, Beck AR, S-Y Ung B, Caruso MC, Moore C, Hocking A, Johnson IRD, Li KL, Karageorgos L, Hopkins AM, Esterman AJ, Huzzell C, Brooks RD, Lazniewska J, Hickey SM, Bader C, Parkinson-Lawrence E, Weigert R, Sorich MJ, Tewari P, Martin C, O'Toole S, Bates M, Ward M, Mohammed B, Keegan H, Watson W, Prendergast S, Heffernan S, NiMhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Brady N, Clarke A, Sokol F, Prabhakaran S, Stahl J, Klebe S, Samaratunga H, Delahunt B, Selemidis S, Moretti KL, Butler LM, O'Leary JJ, Brooks DA. | 01/28/2023 |
Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitis. | Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Yilmaz PD, Kadiyoran C, Goktepe MH, Akkubak Y, Icli A, Kucuk A. | 12/31/2022 |
Expression of syndecan-1 in different grades of oral squamous cell carcinoma: An immunohistochemical study. | Expression of syndecan-1 in different grades of oral squamous cell carcinoma: An immunohistochemical study. Shetty PK, Gonsalves N, Desai D, Pandit S, Aradhya C, Shahid M, Shubhalakshmi, Shetty SJ. | 12/24/2022 |
The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast. | The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast. D'Arcy C, Zimmermann CC, Espinoza-Sanchez NA, Greve B, Schmidt A, Kiesel L, von Wahlde MK, Götte M. | 10/1/2022 |
miR-335-5p Targets SDC1 to Regulate the Progression of Breast Cancer. | miR-335-5p Targets SDC1 to Regulate the Progression of Breast Cancer. Song G, Ma Y, Ma Y, Liu P, Hou L, Xu Z, Jiang J, Shen Y, Cao Y, Zhao Y. | 08/27/2022 |
Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. | Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Chen K, Wang Y, Hou Y, Wang Q, Long D, Liu X, Tian X, Yang Y. | 08/27/2022 |
Syndecan-1 in liver pathophysiology. | Syndecan-1 in liver pathophysiology. Reszegi A, Tátrai P, Regős E, Kovalszky I, Baghy K. | 07/30/2022 |
Targeting syndecan-1: new opportunities in cancer therapy. | Targeting syndecan-1: new opportunities in cancer therapy. Yang Z, Chen S, Ying H, Yao W., Free PMC Article | 07/2/2022 |